XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net revenue        
Total net revenue $ 1,968,000 $ 3,066,000 $ 3,228,000 $ 6,586,000
Cost of net revenue 604,000 1,228,000 1,134,000 2,582,000
Gross profit 1,364,000 1,838,000 2,094,000 4,004,000
Operating expenses        
Research and development 985,000 981,000 1,946,000 2,134,000
Selling, general and administrative 964,000 932,000 2,099,000 1,904,000
Total operating expenses 1,949,000 1,913,000 4,045,000 4,038,000
Loss from operations (585,000) (75,000) (1,951,000) (34,000)
Interest expense (56,000) (56,000) (111,000) (110,000)
Other income, net 2,000 28,000 18,000 51,000
Net loss (639,000) (103,000) (2,044,000) (93,000)
Deemed dividend for warrant exercise price adjustment (392,000)   (392,000)  
Net loss attributable to common stockholders $ (1,031,000) $ (103,000) $ (2,436,000) $ (93,000)
Net loss per share attributable to common stockholders        
Basic and diluted $ (0.32) $ (0.05) $ (0.88) $ (0.04)
Shares used in computing net loss per share        
Basic and diluted 3,265 2,159 2,780 2,156
Other comprehensive income, net of tax:        
Net loss $ (639,000) $ (103,000) $ (2,044,000) $ (93,000)
Net unrealized gains on available-for-sale securities   1,000   1,000
Comprehensive loss (639,000) (102,000) (2,044,000) (92,000)
Product        
Net revenue        
Total net revenue 1,679,000 2,810,000 2,747,000 6,196,000
Royalty and Other        
Net revenue        
Total net revenue $ 289,000 $ 256,000 $ 481,000 $ 390,000